Search - tctmd.com

Displaying 21 - 40 of 105

Sort: Relevancy | Date

News Conference News TCT 2019

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Michael O'Riordan

September 27, 2019

News Conference News TCT 2019

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

Yael L. Maxwell

September 27, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Two: Transcatheter Valves, New and Old

Shelley Wood

September 27, 2019

Presentation TCT 2019

Remaining Data Gaps After the Low-Risk TAVR RCTs

Presenter: Michael Borger

September 26, 2019

Presentation TCT 2019

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Presenter: Michael Reardon

September 26, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

Presentation TCT 2019

TCT 20: Aortic Root Anatomy in Low Risk Patients After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve: Impact on Coronary Access and Repeat Aortic Valve Interventions

Presenter: Toby Rogers

September 25, 2019

Presentation TCT 2019

The Clinical Evidence: Extreme- to Low-Risk Patients

Presenter: Michael Reardon

September 25, 2019

News Daily News

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Yael L. Maxwell

September 18, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2019

Shelley Wood

August 30, 2019

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

News Daily News

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Caitlin E. Cox

August 21, 2019

News Daily News

Expert Consensus Gives Initial Guidance on Post-TAVR Conduction Disturbances

Yael L. Maxwell

August 20, 2019

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

News Industry News

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

August 16, 2019

News Daily News

TAVR Bleeds Stand Apart From PCI-Related Events

Caitlin E. Cox

August 06, 2019

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

News Daily News

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Todd Neale

July 19, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

Advertisement

Transcatheter Options Best for Tricuspid Regurgitation in Matched Registry Analysis

Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT

Transseptal Transcatheter Mitral Valve-in-Valve Ups Survival in High-Risk Patients

TCT 2019 Day Two: Transcatheter Valves, New and Old

Remaining Data Gaps After the Low-Risk TAVR RCTs

Deep-Dive: NEW Insights From the Evolut Low-Risk Trial

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

TCT 20: Aortic Root Anatomy in Low Risk Patients After Transcatheter Aortic Valve Replacement with a Balloon-Expandable Valve: Impact on Coronary Access and Repeat Aortic Valve Interventions

The Clinical Evidence: Extreme- to Low-Risk Patients

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

TCTMD’s Top 10 Most Popular Stories for August 2019

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Antiplatelets Protective Post-TAVR in A-fib Patients: PARTNER II Data

Expert Consensus Gives Initial Guidance on Post-TAVR Conduction Disturbances

FDA Expands TAVR Indication to Low-Risk Patients

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

TAVR Bleeds Stand Apart From PCI-Related Events

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Machine Learning Helps Predict In-Hospital Mortality Post-TAVR, but Skepticism Abounds

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content